A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903

NCT04762407 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HGP1910
DRUG: HGP1909
DRUG: HCP1903

Sponsor

Hanmi Pharmaceutical Company Limited